Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2011 Nov 1;5(6):1557-62.
doi: 10.1177/193229681100500632.

A review of the security of insulin pump infusion systems

Affiliations
Review

A review of the security of insulin pump infusion systems

Nathanael Paul et al. J Diabetes Sci Technol. .

Abstract

Insulin therapy has enabled patients with diabetes to maintain blood glucose control to lead healthier lives. Today, rather than injecting insulin manually using syringes, a patient can use a device such as an insulin pump to deliver insulin programmatically. This allows for more granular insulin delivery while attaining blood glucose control. Insulin pump system features have increasingly benefited patients, but the complexity of the resulting system has grown in parallel. As a result, security breaches that can negatively affect patient health are now possible. Rather than focus on the security of a single device, we concentrate on protecting the security of the entire system. In this article, we describe the security issues as they pertain to an insulin pump system that includes an embedded system of components, which include the insulin pump, continuous glucose management system, blood glucose monitor, and other associated devices (e.g., a mobile phone or personal computer). We detail not only the growing wireless communication threat in each system component, but also describe additional threats to the system (e.g., availability and integrity). Our goal is to help create a trustworthy infusion pump system that will ultimately strengthen pump safety, and we describe mitigating solutions to address identified security issues.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Insulin pump system

References

    1. LCDR Alan Stevens, FDA Infusion Pump Team Leader. Insulin Pumps. Public Workshop: Innovations in Technology for the Treatment of Diabetes: Clinical Development of the Artificial Pancreas (an Autonomous System); 2010 Nov 10; available from: http://fda.yorkcast.com/webcast/Viewer/?peid=c99b98eac96d45dd90de77c6e35.... - PMC - PubMed
    1. White Paper: Infusion Pump Improvement Initiative. April 22,2010. Availablefrom: http://www.fda.gov/medicaldevices/productsandmedicalprocedures/GeneralHo.... Accessed on October 31, 2011.
    1. Maisel WH, Kohno T. Improving the security and privacy of implantable medical devices. N Engl J Med. 2010;362(13):1164–1166. - PubMed
    1. Guidance for Industry and FDA Staff—Total Product Life Cycle: Infusion Pump—Premarket Notification [510(k)] Submissions Draft Guidance. April 23, 2010. Available from: http://www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/GuidanceDo.... Accessed on October 31, 2011.
    1. Senesh G, Bushi D, Neta A, Yodfat O. Compatibility of insulin Lispro, Aspart, and Glulisine with the Solo MicroPump, a novel miniature insulin pump. J Diabetes Sci Technol. 2010;4(1):104–110. - PMC - PubMed

Publication types

MeSH terms